Bollard Group’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-387
| Closed | -$6K | – | 304 |
|
|
2022
Q1 | $6K | Hold |
387
| – | – | ﹤0.01% | 413 |
|
|
2021
Q4 | $10K | Hold |
387
| – | – | ﹤0.01% | 411 |
|
|
2021
Q3 | $17K | Hold |
387
| – | – | ﹤0.01% | 395 |
|
|
2021
Q2 | $16K | Hold |
387
| – | – | ﹤0.01% | 398 |
|
|
2021
Q1 | $21K | Hold |
387
| – | – | ﹤0.01% | 392 |
|
|
2020
Q4 | $15K | Hold |
387
| – | – | ﹤0.01% | 398 |
|
|
2020
Q3 | $22K | Hold |
387
| – | – | ﹤0.01% | 380 |
|
|
2020
Q2 | $29K | Buy |
+387
| New | +$29K | ﹤0.01% | 390 |
|